Lv1
58 积分 2024-02-05 加入
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
3天前
已完结
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial
3天前
已完结
Pharmacokinetics, pharmacodynamics and safety profile of SKB336, a selective inhibitor of coagulation factor XI/XIa in healthy subjects
5天前
已完结
Pharmacokinetics, pharmacodynamics and safety profile of SKB336, a selective inhibitor of coagulation factor XI/XIa in healthy subjects
20天前
已完结
New therapies to treat cardiac amyloidosis
1个月前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
1个月前
已完结
Differential Effects of Volanesorsen on ApoC-III, Triglycerides and Pancreatitis in Familial Chylomicronemia Syndrome Diagnosed by Genetic or Non-Genetic Criteria
2个月前
已完结
Differential Effects of Volanesorsen on ApoC-III, Triglycerides and Pancreatitis in Familial Chylomicronemia Syndrome Diagnosed by Genetic or Non-Genetic Criteria
3个月前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
3个月前
已完结
APOC3 siRNA and ASO therapy for dyslipidemia
3个月前
已完结
皖公网安备34019202002308
